Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.
Scanvion Q, Béné J, Gautier S, Grandvuillemin A, Le Beller C, Chenaf C, Etienne N, Brousseau S, Cortot AB, Mortier L, Staumont-Sallé D, Morschhauser F, Forestier A, Groh M, Launay D, Hachulla E, Labalette M, Kahn JE, Lefèvre G.
Scanvion Q, et al. Among authors: gautier s.
Oncoimmunology. 2020 Apr 7;9(1):1722022. doi: 10.1080/2162402X.2020.1722022. eCollection 2020.
Oncoimmunology. 2020.
PMID: 32313716
Free PMC article.